Quanterix Corporation (QTRX)
QTRX Stock Price Chart
Explore Quanterix Corporation interactive price chart. Choose custom timeframes to analyze QTRX price movements and trends.
QTRX Company Profile
Discover essential business fundamentals and corporate details for Quanterix Corporation (QTRX) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
7 Dec 2017
Employees
471.00
Website
https://www.quanterix.comCEO
Masoud Toloue
Description
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids. The company also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assay kits and other consumables such as reagents. In addition, it offers contract research services, including sample testing, homebrew assay development, and custom development services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct sales force, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
QTRX Financial Timeline
Browse a chronological timeline of Quanterix Corporation corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 22 Dec 2025
EPS estimate is -$0.23.
Upcoming earnings on 10 Nov 2025
Earnings released on 7 Aug 2025
EPS came in at -$0.47 falling short of the estimated -$0.41 by -14.63%, while revenue for the quarter reached $24.48M , missing expectations by -36.44%.
Earnings released on 12 May 2025
EPS came in at -$0.53 surpassing the estimated -$0.69 by +23.19%, while revenue for the quarter reached $30.33M , beating expectations by +7.29%.
Earnings released on 17 Mar 2025
EPS came in at -$0.30 falling short of the estimated -$0.27 by -11.11%, while revenue for the quarter reached $35.16M , beating expectations by +0.66%.
Earnings released on 23 Dec 2024
EPS came in at -$0.22 surpassing the estimated -$0.24 by +8.33%, while revenue for the quarter reached $35.41M , beating expectations by +3.74%.
Earnings released on 8 Aug 2024
EPS came in at -$0.25 falling short of the estimated -$0.23 by -8.70%, while revenue for the quarter reached $34.38M , beating expectations by +2.02%.
Earnings released on 7 May 2024
EPS came in at -$0.26 surpassing the estimated -$0.33 by +21.21%, while revenue for the quarter reached $32.07M , beating expectations by +1.41%.
Earnings released on 29 Feb 2024
EPS came in at -$0.33 falling short of the estimated -$0.28 by -17.86%, while revenue for the quarter reached $31.55M , beating expectations by +5.73%.
Earnings released on 6 Nov 2023
EPS came in at -$0.21 surpassing the estimated -$0.35 by +40.00%, while revenue for the quarter reached $30.84M , beating expectations by +8.80%.
Earnings released on 7 Aug 2023
EPS came in at -$0.16 surpassing the estimated -$0.36 by +55.56%, while revenue for the quarter reached $30.87M , beating expectations by +16.33%.
Earnings released on 9 May 2023
EPS came in at -$0.16 surpassing the estimated -$0.36 by +55.56%, while revenue for the quarter reached $28.23M , beating expectations by +11.16%.
Earnings released on 6 Mar 2023
EPS came in at -$0.50 surpassing the estimated -$0.53 by +5.66%, while revenue for the quarter reached $25.61M , missing expectations by -0.67%.
Earnings released on 8 Nov 2022
EPS came in at -$0.40 surpassing the estimated -$0.42 by +4.76%, while revenue for the quarter reached $26.36M , beating expectations by +9.74%.
Earnings released on 8 Aug 2022
EPS came in at -$0.67 matching the estimated -$0.67, while revenue for the quarter reached $23.43M , missing expectations by -22.05%.
Earnings released on 10 May 2022
EPS came in at -$0.49 surpassing the estimated -$0.67 by +26.87%, while revenue for the quarter reached $29.55M , beating expectations by +1.54%.
Earnings released on 1 Mar 2022
EPS came in at -$0.55 surpassing the estimated -$0.69 by +20.29%, while revenue for the quarter reached $30.29M , beating expectations by +6.98%.
Earnings released on 4 Nov 2021
EPS came in at -$0.43 falling short of the estimated -$0.30 by -43.33%, while revenue for the quarter reached $26.68M , beating expectations by +11.12%.
Earnings released on 5 Aug 2021
EPS came in at -$0.33 falling short of the estimated -$0.32 by -3.13%, while revenue for the quarter reached $24.43M , missing expectations by -3.71%.
Earnings released on 5 May 2021
EPS came in at -$0.29 surpassing the estimated -$0.32 by +9.38%, while revenue for the quarter reached $24.92M , missing expectations by -18.32%.
Earnings released on 2 Mar 2021
EPS came in at -$0.31 falling short of the estimated -$0.30 by -3.33%, while revenue for the quarter reached $26.13M .
Earnings released on 5 Nov 2020
EPS came in at $0.07 surpassing the estimated -$0.42 by +116.67%, while revenue for the quarter reached $29.46M , missing expectations by -51.87%.
QTRX Stock Performance
Access detailed QTRX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.